Can Personalized Medicine Help in Managing Neonatal Respiratory Distress Syndrome (RDS)?
Yes, personalized medicine can play a crucial role in managing neonatal respiratory distress syndrome (RDS). By analyzing genetic and epigenetic factors that affect lung development and function, healthcare providers can predict which newborns are at higher risk for RDS. This information can inform decisions regarding the timing and type of surfactant therapy, mechanical ventilation strategies, and other supportive measures.
